FOUNTAINHEAD CAPITAL MANAGEMENT LTD 13D and 13G filings for Vycor Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-18 4:54 pm Purchase | 2022-09-30 | 13D | VYCOR MEDICAL, INC. VYCO | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | 20,340,520 62.530% | 535,714 (+2.70%) | Filing |
| 2022-07-13 06:05 am Purchase | 2022-06-30 | 13D | VYCOR MEDICAL, INC. VYCO | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | 19,804,806 61.910% | 535,714 (+2.78%) | Filing |
| 2022-04-13 5:24 pm Purchase | 2022-03-31 | 13D | VYCOR MEDICAL, INC. VYCO | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | 19,269,092 61.260% | 535,714 (+2.86%) | Filing |
| 2022-01-18 06:15 am Purchase | 2021-12-31 | 13D | VYCOR MEDICAL, INC. VYCO | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | 18,733,378 59.880% | 535,714 (+2.94%) | Filing |
| 2021-10-08 1:22 pm Purchase | 2021-09-30 | 13D | VYCOR MEDICAL, INC. VYCO | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | 18,197,664 59.180% | 535,714 (+3.03%) | Filing |